BIOCRYST PHARMACEUTICALS INC Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Biocryst Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Biocryst Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 207M shares, a 9.12% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 207M +17.3M +9.12% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 207M +17.1M +9.04% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 206M +17.5M +9.25% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 206M +17.9M +9.51% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 190M +3.39M +1.82% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 189M +3.62M +1.95% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 189M +3.31M +1.78% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 188M +3.56M +1.93% Dec 31, 2022 10-K 2024-02-27
Q3 2022 186M +6.62M +3.68% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 186M +7.15M +4% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 186M +7.9M +4.45% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 184M +7.47M +4.22% Dec 31, 2021 10-K 2023-02-27
Q3 2021 180M +3.23M +1.83% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 179M +2.3M +1.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 178M +23.5M +15.2% Mar 31, 2021 10-Q 2021-05-07
Q4 2020 177M +22.8M +14.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 177M +66.1M +59.9% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 176M +66.1M +59.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 154M +43.9M +39.8% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 154M +44M +40% Dec 31, 2019 10-K 2021-03-01
Q3 2019 110M +813K +0.74% Sep 30, 2019 10-Q 2019-11-08
Q2 2019 110M +11.4M +11.6% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 110M +11.6M +11.7% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 110M +11.7M +11.8% Dec 31, 2018 10-K 2020-03-13
Q3 2018 110M +11.2M +11.4% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 98.9M +18.5M +23% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 98.7M +18.3M +22.8% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 98.4M +24.6M +33.4% Dec 31, 2017 10-K 2019-03-14
Q3 2017 98.4M +24.6M +33.4% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 80.4M +6.73M +9.13% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 80.4M +6.69M +9.08% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 73.8M +427K +0.58% Dec 31, 2016 10-K 2018-03-12
Q3 2016 73.8M +421K +0.57% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 73.7M +533K +0.73% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 73.7M +1.22M +1.68% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 73.4M +1.4M +1.95% Dec 31, 2015 10-K 2017-02-27
Q3 2015 73.3M +1.48M +2.05% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 73.2M +1.45M +2.02% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 72.5M +12.4M +20.7% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 72M +12.9M +21.8% Dec 31, 2014 10-K 2016-02-26
Q3 2014 71.9M +12.8M +21.6% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 71.7M +17.5M +32.3% Jun 30, 2014 10-Q 2014-08-08
Q1 2014 60.1M +8.66M +16.8% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 59.1M +8.2M +16.1% Dec 31, 2013 10-K 2015-03-02
Q3 2013 59.1M +8.21M +16.1% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 54.2M +4.07M +8.12% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 51.4M +2.25M +4.58% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 50.9M +5.23M +11.5% Dec 31, 2012 10-K 2014-03-10
Q3 2012 50.9M +50.8M Sep 30, 2012 10-Q 2012-11-08
Q2 2012 50.1M +50.1M Jun 30, 2012 10-Q 2012-08-08
Q1 2012 49.2M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 45.7M +703K +1.56% Dec 31, 2011 10-K 2013-03-11
Q3 2011 45.2K* Sep 30, 2011 10-Q 2011-11-03
Q2 2011 45.2K* Jun 30, 2011 10-Q 2011-08-04
Q4 2010 45M Dec 31, 2010 10-K 2012-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.